Exciting news in the tech industry as Mantle, the San Francisco-based company revolutionizing manufacturing with its TrueShape metal 3D printing technology, just announced a successful funding round of $20 million. The company, known for its patented technology that streamlines the production of precision parts for tools, molds, and dies, is on a mission to speed up the product development process while reducing costs for manufacturers. The latest funding will fuel Mantle's continued efforts to expand its innovative solutions and reach even more clients looking to optimize their manufacturing processes. With a track record of delivering top-quality parts quickly and affordably, Mantle is set to make waves in the manufacturing world with this significant financial injection.
Mantle Secures $20 Million in Series C Funding to Revolutionize Metal 3D Printing Technology
Recently funded 路 $20.0M Series cManufacturing/Technology
Get the full Mantle company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  SOLIVIS | Series c | $16.0M | 1d ago |
| 2 |  SKAN Switzerland | Series c | $63.0M | 1d ago |
| 3 |
